Detalhe da pesquisa
1.
Supramolecular assemblies from antimony(V) complexes for the treatment of leishmaniasis.
Biophys Rev
; 15(4): 751-765, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37681109
2.
Nanoassemblies from Amphiphilic Sb Complexes Target Infection Sites in Models of Visceral and Cutaneous Leishmaniases.
Pharmaceutics
; 14(8)2022 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36015369
3.
Liposomal Amphotericin B for Treatment of Leishmaniasis: From the Identification of Critical Physicochemical Attributes to the Design of Effective Topical and Oral Formulations.
Pharmaceutics
; 15(1)2022 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36678729
4.
Formulation of Amphotericin B in PEGylated Liposomes for Improved Treatment of Cutaneous Leishmaniasis by Parenteral and Oral Routes.
Pharmaceutics
; 14(5)2022 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35631575
5.
Antileishmanial activity of fullerol and its liposomal formulation in experimental models of visceral leishmaniasis.
Biomed Pharmacother
; 134: 111120, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33341671